Voltage-dependent calcium channel subunit alpha-2-delta-1 (CACNA2D1)

The voltage-dependent calcium channel subunit alpha-2-delta-1 (CACNA2D1) is an auxiliary protein that regulates the function and trafficking of high-voltage-activated calcium channels (VGCCs) in the nervous system and muscle tissue [4, 7]. It consists of an alpha-2 and a delta subunit derived from a single preproprotein linked by a disulfide bond [12]. Its primary biological roles include increasing the density of VGCCs at the plasma membrane, modulating channel kinetics, and facilitating synaptogenesis through interactions with extracellular matrix proteins like thrombospondins [15, 17]. In pathological conditions such as peripheral nerve injury, the expression of CACNA2D1 is significantly upregulated in dorsal root ganglia and the spinal cord, leading to neuronal hyperexcitability and the development of chronic neuropathic pain [2, 18]. It also plays a role in cardiac rhythm regulation and has been linked to genetic conditions like Brugada syndrome and epilepsy [12, 13]. CACNA2D1 is the primary molecular target for gabapentinoid drugs, such as gabapentin and pregabalin [2, 9, 16]. These drugs bind to the subunit to inhibit its trafficking and reduce the release of excitatory neurotransmitters, making the subunit a critical therapeutic focus for pain management and seizure control [3, 10].

Other names

Alpha2delta-1α2δ-1CACNA2CACNL2ACCHL2ACalcium voltage-gated channel auxiliary subunit alpha2delta 1Voltage-dependent calcium channel subunit alpha-2/delta-1

Binding of gabapentinoid drugs to the alpha-2-delta-1 subunit inhibits the trafficking of the subunit and its associated calcium channel complexes from the endoplasmic reticulum to the presynaptic membrane, thereby reducing the release of excitatory neurotransmitters like glutamate and decreasing neuronal hyperexcitability [3, 6, 10].